These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 30271000)
1. Warfarin-related nephropathy: unveiling the hidden dangers of anticoagulation. Xu F; Wang G; Sun L; Cheng H Clin Exp Med; 2024 Jul; 24(1):148. PubMed ID: 38960929 [TBL] [Abstract][Full Text] [Related]
2. Acute Kidney Injury in Different Anticoagulation Strategies: A Large-Scale Pharmacoepidemiologic Study Using Real-World Data. Xu Q; Chen G; Ai S; Zheng K; Zhao B; Li X Cardiovasc Drugs Ther; 2024 Feb; ():. PubMed ID: 38319470 [TBL] [Abstract][Full Text] [Related]
3. Dabigatran-Related Nephropathy in a Patient with Undiagnosed IgA Nephropathy. Escoli R; Santos P; Andrade S; Carvalho F Case Rep Nephrol; 2015; 2015():298261. PubMed ID: 26347498 [TBL] [Abstract][Full Text] [Related]
4. Warfarin-related nephropathy: A case report of a delayed renal function improvement. Nonaka E; Takashima T; Matsumoto K; Fukuda M; Rikitake S; Miyazono M Clin Case Rep; 2021 May; 9(5):e04105. PubMed ID: 34026147 [TBL] [Abstract][Full Text] [Related]
8. Anticoagulant-Related Nephropathy in Kidney Biopsy: A Single-Center Report of 41 Cases. Brodsky SV; Satoskar A; Hemminger J; Rovin B; Hebert L; Ryan MS; Nadasdy T Kidney Med; 2019; 1(2):51-56. PubMed ID: 32715287 [TBL] [Abstract][Full Text] [Related]
9. Dabigatran-induced anticoagulant-related nephropathy with undiagnosed IgA nephropathy in a patient with normal baseline renal function. Ikeda M; Tanaka M; Shimoda S; Saita H; Nishikawa S; Shimada H; Taniguchi K; Hagihara K; Iwanari S; Takeoka H CEN Case Rep; 2019 Nov; 8(4):292-296. PubMed ID: 31347098 [TBL] [Abstract][Full Text] [Related]
10. IgA Nephropathy Is the Most Common Underlying Disease in Patients With Anticoagulant-Related Nephropathy. Trujillo H; Sandino J; Cavero T; Caravaca-Fontán F; Gutiérrez E; Sevillano ÁM; Shabaka A; Fernández-Juárez G; Rodríguez Doyágüez P; Gimena Muñoz R; Calle García L; Cabello V; Muñoz-Terol JM; García Santiago A; Toldos O; Moreno JA; Praga M Kidney Int Rep; 2022 Apr; 7(4):831-840. PubMed ID: 35497792 [TBL] [Abstract][Full Text] [Related]
12. Non-Vitamin K Antagonist Oral Anticoagulants Provide Less Adverse Renal Outcomes Than Warfarin In Non-Valvular Atrial Fibrillation: A Systematic Review and MetaAnalysis. Sitticharoenchai P; Takkavatakarn K; Boonyaratavej S; Praditpornsilpa K; Eiam-Ong S; Susantitaphong P J Am Heart Assoc; 2021 Apr; 10(7):e019609. PubMed ID: 33728927 [TBL] [Abstract][Full Text] [Related]
13. Management of Anticoagulant-Related Nephropathy: A Single Center Experience. Belčič Mikič T; Kojc N; Frelih M; Aleš-Rigler A; Večerić-Haler Ž J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33669373 [TBL] [Abstract][Full Text] [Related]
14. My Bleeding Nephrons! Li J; Padala SA; Hinnant G; Vakiti A; Mohammed A J Investig Med High Impact Case Rep; 2019; 7():2324709619858126. PubMed ID: 31216916 [TBL] [Abstract][Full Text] [Related]
16. Warfarin related nephropathy: a case report and review of the literature. Ng CY; Tan CS; Chin CT; Lim SL; Zhu L; Woo KT; Tan PH BMC Nephrol; 2016 Feb; 17():15. PubMed ID: 26830352 [TBL] [Abstract][Full Text] [Related]
17. Warfarin: A double-edged sword. Yadav P; Yadav S; Pathak S J Family Med Prim Care; 2019 Sep; 8(9):3045-3047. PubMed ID: 31681692 [TBL] [Abstract][Full Text] [Related]